Oncology Instituteの空売り状況は、投資家がOncology Instituteの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Oncology Institute (NASDAQ:TOI) 株価情報, 空売り情報

Oncology Institute

The Oncology Institute

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.

The Oncology Institute, Inc. - Common Stock

The Oncology Institute Inc

THAI OIL PCL FGN REG SHS by Thai Oil Public Co., Ltd.

Thai Oil PCL

THAI OIL PCL UNSP/ADR by Thai Oil Public Co., Ltd.

TOPICUS COM INC SUB VTG by TOPICUS COM INC.

Topicus com Inc

Once you have been in the financial publishing industry long enough, you realize that people write a lot of what passes for content and analysis that have no idea how markets and economics work.
They know little to nothing about behavioral economics or balance sheet analysis.
They have never worked on a desk, been in a pit, dealt with a margin call, or taken panicked phone calls from investors after a market crash.
They have degrees in English, Communication, and, worst of all, Marketing.
They write about what everyone else writes about.
They care about clicks and not profits.
They can write an elegantly structured paragraph summarizing a recent PR puff piece, which is about as valuable as government peanut butter and cheese.
It fills space but does not have much value.
This becomes glaringly obvious when you read the nonsense that gets written about institutional buying and selling activities.
I regularly see articles that breathlessly announce that Vanguard has bought or sold a major portion of a company.
We also see announcements involving activity by BlackRock and Fidelity, and the articles imply that these purchases have some meaning.
They do not.
Vanguard and BlackRock are the largest purveyors of index funds. Their buying and selling may tell a story about fund flows, but the individual security activity is meaningless.
Fidelity is so big that if they look at a company, they accidentally cross the 5% ownership threshold that triggers an SEC filing.
Tracking institutional activity is valuable if you know which transactions matter and which ones do not.
Vanguard buying shares of Robinhood (Ticker: HOOD) and selling some Nikola (Ticker: NKLA does not mean anything to stock investors looking for potential bargains.
Several institutions with specialized information and vital track records buying into a beaten-up sector potentially has enormous value.
One of the most beaten-up sectors is real estate.
As all the Instant Experts on the Internet will inform you, real estate is the single worst asset class in the history of assets.
There is an excellent chance that no one will ever go into an office again.
We have so many apartments that the suburbs look like scenes from a post-apocalyptic Western, with tumbleweeds blowing through mile after mile of empty apartment buildings.
No one goes to shopping centers anymore.
Everything is delivered.
All those cars are just using the free parking spaces.
The banking system is so choked with bad real estate loans that it will collapse any day and be replaced by the newest top-secret penny crypto, which has the potential to make you a billionaire in a week starting next Tuesday.
I have heard these types of stories swirling around real estate before and during my career.
Texas real estate was a disaster in the 1980s, and you could barely give it away.
In the aftermath of the S&amp;L crisis in the 1980s and early 1990s, real estate attracted all sorts of negative attention.
It was even worse in the aftermath of the internet bubble bursting.
The Great Financial Crisis was the gold standard for toxic real estate conversations.
Each time the smart money piled in and made a fortune.
According to recent SEC filings, they are doing it again this time.
The Macquarie Group is a division of the Macquarie Bank in Sydney, Australia. The group handles the bank&#8217;s business and investing outside of Australia and has had quite a reputation over the years as a very shrewd and profitable dealmaker.
In the second half of 2024, Macquarie Group has been moving into US real estate.
The firm just filed forms with the SEC revealing it now owns over 5% of Lexington Realty Trust, an owner of single-tenant warehouse and industrial properties in Ohio, Indiana, South Carolina, Georgia, and Arizona.
The firm is clearly very bullish on the single-tenant industrial markets as it has also been buying shares of Plymouth Industrial REIT (Ticker: PLYM) this year.
The firm is also a large owner and frequent buyer of VICI Properties (Ticker: VICI), an owner of casinos with a strong presence in the Las Vegas market and an outstanding history of growing both cash flows and dividend payouts.
Robert Robotti is one of those under-the-radar value investors most people do not know exist, but since opening his doors over 40 years ago, he has crushed the markets.
Robotti recently filed paperwork with the SEC revealing that he now owns 9.7% of Five Points Holdings (Ticker: FPH), a master-planned community developer that combines residential, commercial, retail, educational, and recreational elements.
The Irvine, California, company does business in Orange County, Los Angeles County, and San Francisco County and has not been a favorite of the markets since its IPO in 2017.
Sam Levinson, the Chief Investment Officer at Glick Family Investments and member of the Five Points Board, has also been making large purchases of the stock recently.
The stock is ridiculously undervalued, with shares trading at 4.4 times free cash flow and 41% of tangible book value.
If Five Points just survives, you have a strong chance of at least doubling your money.
Robotti also accumulated shares of Legacy Homes (Ticker: LEGH), a builder of manufactured and tiny homes, earlier this year.
Smart money is moving into real estate at current prices.
For what it is worth, fund flows are even forcing indexers like Vanguard and BlackRock to buy real estate-related companies.
The Instant Experts of the Internet hate what the smart money is buying. That is an excellent buy signal in our book.

Opinion

HOOD

LEGH

PLYM

VICI

C-Suite Buys of the Week: Decoding Smart Money Moves in Real Estate

Canaccord Genuity analyst Richard Close maintains Waystar Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAY#NASDAQ">WAY</a>) with a Buy and raises the price target from $30 to $36.

News

Price Target

Analyst Ratings

Canaccord Genuity Maintains Buy on Waystar Holding, Raises Price Target to $36

Turning Point Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>), a maker of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced its financial results Thursday for the third quarter ended Sept. 30, 2024.
The company behind Zig-Zag, a brand of rolling papers in the cannabis industry, said total consolidated net sales increased 3.8% year over year to $105.6 million.
Zig-Zag products&#8217; net sales, which accounted for 47% of total net sales in the quarter, increased 5.5% over the same period to $49.3 million, driven by strong performance in our North American Papers &amp; Wraps business and solid growth in cigars.
Graham Purdy, the company&#8217;s president and CEO, said Zig-Zag is on "a sustainable growth trajectory."
Zig-Zag Products segment gross profit increased 2.2% to $27.3 million. Gross margin declined 180 basis points to 55.4% driven primarily by product mix.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40108639/zig-zag-segment-on-sustainable-growth-trajectory-turning-point-ceo-reports-7-yoy-improvement-in-">Zig-Zag Segment On Sustainable Growth Trajectory, Turning Point CEO Reports 7% YoY Improvement In Adjusted EBITDA, Raises 2024 Guidance</a>
<h3 class="wp-block-heading">Other Q3 Financial Highlights</h3>
<ul>
<li>Gross profit totaled $53.7 million, up from $51.6 million in the prior year's quarter.</li>
<li>Selling, general and administrative expenses amounted to $33.2 million, compared to $31.4 million in the third quarter of last fiscal year.</li>
<li>Net loss attributable to non-controlling interest totaled $16 000, compared to net income attributable to non-controlling interest of $35 000 in the prior year's quarter.</li>
<li>Net income attributable to Turning Point Brands amounted to $12.4 million, up from $10.8 million.</li>
<li>Total gross debt as of Sept. 30, 2024 was $250 million.</li>
<li>Net debt as of Sept. 30, 2024 was $216.4 million.</li>
<li>Ended the quarter with total liquidity of $92.4 million, comprised of $33.6 million in cash and $58.8 million of asset-backed revolving credit facility capacity.</li>
</ul>
<h3 class="wp-block-heading">2024 Outlook</h3>
Turning Point increased its previous full-year 2024 adjusted EBITDA guidance from $98 million to $102 million to $101 million to $103 million, excluding CDS.
During the quarter, the company repurchased 26,978 shares of common stock for $1.1 million.
On Nov. 6, 2024, the board of directors of the company increased the company's share repurchase authorization by $77.9 million to an aggregate amount of $100 million.
Read Next:
<ul>
<li>&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/05/38620478/zig-zag-rolling-paper-sales-made-48-of-total-turning-point-brands-sales-in-first-quarter">Zig-Zag Rolling Paper Sales Made 48% Of Total Turning Point Brands Sales In First Quarter</a></li>
</ul>
<h3 class="wp-block-heading">TPB Price Action</h3>
Turning Point Brands' shares traded 1.31% lower at $50.37 per share at the time of writing on Thursday.

Cannabis

Earnings

Zig-Zag Rolling Papers Segment Drives 47% Of Turning Point Brands' Q3 Sales, CEO Predicts Sustainable Growth

Canaccord Genuity analyst Maria Ripps maintains Upwork (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) with a Buy and raises the price target from $15 to $18.

UPWK

Canaccord Genuity Maintains Buy on Upwork, Raises Price Target to $18

Trading Ideas

CELU

Celularity Shares Resume Trading

Canaccord Genuity analyst William Plovanic maintains Tandem Diabetes Care (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) with a Buy and lowers the price target from $57 to $56.

TNDM

Canaccord Genuity Maintains Buy on Tandem Diabetes Care, Lowers Price Target to $56

Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) reported better-than-expected earnings for the <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5978b62d43229a0001537151/mark-miller">first quarter on Wednesday</a>.
The company posted quarterly earnings of 74 cents per share which beat the analyst consensus estimate of 61 cents per share. The company reported quarterly sales of $1.35 billion which beat the analyst consensus estimate of $1.31 billion.
Jim Anderson, CEO, said, &#8220;We delivered solid growth in the September quarter on both a sequential and year-over-year basis, driven primarily by our AI-related Datacom transceivers. We also drove higher gross margin and operating margin. I continue to be excited by the opportunity to unlock significant long-term shareholder value.&#8221;
Coherent said it sees second-quarter revenue of $1.33 billion to $1.41 billion and adjusted EPS of 61 cents to 77 cents.
Coherent shares gained 5.3% to trade at $104.72 on Thursday.
These analysts made changes to their price targets on Coherent following earnings announcement.
<ul>
<li>Benchmark analyst Mark Miller maintained Coherent with a Buy and raised the price target from $90 to $112.</li>
<li>Susquehanna analyst Mehdi Hosseini maintained Coherent with a Positive and raised the price target from $120 to $125.</li>
<li>Citigroup analyst Atif Malik maintained Coherent with a Buy and raised the price target from $88 to $106.</li>
</ul>
Considering buying COHR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="476" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07134102/image-83-1024x476.png" alt="" class="wp-image-636077" style="width:637px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07134102/image-83-1024x476.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07134102/image-83-300x140.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07134102/image-83-768x357.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07134102/image-83.png 1230w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41809435/how-to-earn-500-a-month-from-nvidia-stock-after-trump-win">How To Earn $500 A Month From Nvidia Stock After Trump Win</a></li>
</ul>

Markets

COHR

Coherent Analysts Boost Their Forecasts Following Better-Than-Expected Earnings

Canaccord Genuity analyst Michael Graham maintains Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) with a Buy and raises the price target from $18 to $22.

LYFT

Canaccord Genuity Maintains Buy on Lyft, Raises Price Target to $22

Canaccord Genuity analyst David Hynes maintains Klaviyo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVYO#NYSE">KVYO</a>) with a Buy and raises the price target from $32 to $40.

KVYO

Canaccord Genuity Maintains Buy on Klaviyo, Raises Price Target to $40

B of A Securities analyst Michael McGovern maintains Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) with a Buy and raises the price target from $16 to $19.

B of A Securities Maintains Buy on Lyft, Raises Price Target to $19

JMP Securities analyst Nicholas Jones maintains Zillow Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>) with a Market Outperform and raises the price target from $62 to $82.

JMP Securities Maintains Market Outperform on Zillow Gr, Raises Price Target to $82

Canaccord Genuity analyst Richard Davis maintains HubSpot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) with a Buy and raises the price target from $600 to $710.

HUBS

Canaccord Genuity Maintains Buy on HubSpot, Raises Price Target to $710

Canaccord Genuity analyst David Hynes maintains Freshworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) with a Buy and raises the price target from $17 to $19.

FRSH

Canaccord Genuity Maintains Buy on Freshworks, Raises Price Target to $19

B of A Securities analyst John Murphy maintains Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Buy and raises the price target from $265 to $350.

TSLA

B of A Securities Maintains Buy on Tesla, Raises Price Target to $350

JMP Securities analyst Patrick Walravens maintains Vertex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERX#NASDAQ">VERX</a>) with a Market Outperform and raises the price target from $47 to $61.

VERX

JMP Securities Maintains Market Outperform on Vertex, Raises Price Target to $61

Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) shares are<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> trading lower on Thursday</a>. Bernstein analyst Toni Sacconaghi downgraded Ford Motor from Outperform to Market Perform, <a target="_blank" href="https://www.benzinga.com/quote/F/analyst-ratings" rel="noreferrer noopener">with a price forecast of&nbsp;$11.</a>
In an unrelated development, Ford revealed on Thursday that it is experiencing record sales growth in the Middle East in 2024, driven by strong performance in key markets and the introduction of its <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41799089/fords-winning-lineup-fuels-record-sales-in-the-middle-east-sets-stage-for-electrified-future" rel="noreferrer noopener">freshest lineup to date.</a>
The launch of the Mustang Mach-E and Territory Hybrid highlights Ford&#8217;s commitment to an electrified future in the region.
Kay Hart, president of Ford&#8217;s International Markets Group, stated that the Mustang Mach-E is Ford&#8217;s first fully electric vehicle for the region and described it as one of the most exciting vehicles the company has ever produced.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41814589/why-trumps-boost-to-treasury-yields-inflation-expectations-may-weaken-feds-efforts-" rel="noreferrer noopener">Why Trump&#8217;s Boost To Treasury Yields, Inflation Expectations May Weaken Fed&#8217;s Efforts To Cut Interest Rates</a>
Additionally, Ford highlighted that it is expanding its connected services offering, with the 2025 introduction of FordPass for customers in the Middle East.
&#8220;This success is due to strong market share gains by our distributors in key countries such as the&nbsp;United Arab Emirates,&nbsp;Kuwait,&nbsp;Bahrain,&nbsp;Qatar&nbsp;and&nbsp;Saudi Arabia,&#8221; said&nbsp;Ravi Ravichandran, president of Ford Middle East.
Next year, Ford will accelerate the launch of Ford Connected Services with the FordPass app first in the UAE, followed by&nbsp;Saudi Arabia.
This move further enhances Ford&#8217;s commitment to providing a better connected driving experience.
Ford is also enhancing its regional operations with the opening of a new parts distribution center in the UAE, slated for January 2025. The facility will enable faster delivery of parts to distributors, ensuring quicker service for Ford owners.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, F stock has gained over 8% in the past year. Investors can gain exposure to the stock via First Trust Nasdaq Transportation ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXR#NASDAQ">FTXR</a>) and&nbsp;WBI Power Factor High Dividend ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBIY#NYSE">WBIY</a>).
Price Action: F shares are trading lower by 1.79% to $10.99 at last check Thursday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41807254/trump-election-raises-odds-of-roaring-2020s-scenario-veteran-wall-street-investor-s" target="_blank" rel="noreferrer noopener">Trump Election Raises Odds Of &#8216;Roaring 2020s Scenario,&#8217; Veteran Wall Street Investor Says: How High Could US Stock Market Rise?</a></li>
</ul>

Analyst Color

Equities

Downgrades

Movers

General

FTXR

WBIY

What's Going On With Ford Motor Stock Today?

Canaccord Genuity analyst Susan Anderson maintains e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) with a Buy and lowers the price target from $250 to $200.

Canaccord Genuity Maintains Buy on e.l.f. Beauty, Lowers Price Target to $200

After Wednesday&#8217;s &#8220;everything rally&#8221; spurred by the election results, investors took a less euphoric approach on Thursday ahead of the Federal Open Market Committee (FOMC) meeting.
The Fed is widely expected to cut interest rates by 25 basis points, bringing them to a range of 4.5%-4.75%, following a previous 50-basis-point cut in September.
Yet, all eyes are on Fed Chair Jerome Powell&#8217;s comments at 2:30 p.m. ET regarding the potential for future rate hikes and his views on inflation risks. Concerns from the market center on the possibility of a policy U-turn driven by higher fiscal deficits and price pressures from trade tariffs under a Trump administration.
Tech stocks led gains, with the Nasdaq 100 extending its record-breaking levels, surpassing 21,000 points and eyeing a third consecutive positive session. The S&amp;P 500 and Dow Jones posted more modest gains, while the Russell 2000 paused after Wednesday&#8217;s 5.8% leap.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) remained a top performer among mega-cap stocks, bolstered by expectations of Elon Musk&#8216;s influence in the upcoming administration.
Treasury yields reversed a substantial portion of Wednesday's post-election increase, while the U.S. dollar dipped by 0.7%.
Metal commodities rebounded after Wednesday&#8217;s sharp losses, with gold rising 1.3%, silver up 2% and copper rallying over 4%.
Oil prices strengthened by 1%, with West Texas Intermediate trading around $72 per barrel.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rose 0.8%, reaching $76,000 to extend its record highs, while Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) outperformed with a gain of over 4%.
<h1 class="wp-block-heading">Thursday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,050.78</td>
<td>1.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,968.27</td>
<td>0.7%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,748.20</td>
<td>0.0%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,389.10</td>
<td>-0.2%</td>
</tr>
</tbody>
</table>
</figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent110624&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.7% to $594.84.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;stalled at $437.25.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) soared 1.3% to $512.38.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) eased 0.3% to $236.67.</li>
<li>The Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, rising 1.3%. The Financials Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) lagged, down 1.2%.</li>
</ul>
<h1 class="wp-block-heading">Thursday&#8217;s Stock Movers</h1>
Some relevant reactions to earnings reports are:
<ul>
<li>Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), up 0.1%, </li>
<li>Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>), up 6.2%, </li>
<li>MercadoLibre Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>), down 16%, </li>
<li>APPLovin Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>), up 43%, </li>
<li>McKesson Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCK#NYSE">MCK</a>), up 11%, </li>
<li>Take-Two Interactive Software Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>), up 6.3%, </li>
<li>Transdigm Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDG#NYSE">TDG</a>), down 4.4%</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41814589/why-trumps-boost-to-treasury-yields-inflation-expectations-may-weaken-feds-efforts-">Why Trump&#8217;s Boost To Treasury Yields, Inflation Expectations May Weaken Fed&#8217;s Efforts To Cut Interest Rates</a></li>
</ul>
This image was created using artificial intelligence.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Large Cap

Macro Economic Events

Sector ETFs

Broad U.S. Equity ETFs

Commodities

Economics

Federal Reserve

Tech

ETFs

$BTC

$ETH

SPDR Dow Jones Industrial Average ETF Trust

GILD

MELI

QCOM

TTWO

XLRE

Nasdaq 100 Extends Record Levels Ahead Of Fed Meeting, Tesla Hits 26-Month Highs, Small Caps Stall: What's Driving Markets Thursday?

Canaccord Genuity analyst Michael Graham maintains DoubleVerify Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) with a Buy and lowers the price target from $36 to $30.

Canaccord Genuity Maintains Buy on DoubleVerify Hldgs, Lowers Price Target to $30

JMP Securities analyst Andrew Boone maintains Upwork (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) with a Market Outperform and raises the price target from $14 to $18.

JMP Securities Maintains Market Outperform on Upwork, Raises Price Target to $18

Oncology Institute, Inc. (TOI) has disclosed a new risk, in the Accounting & Financial Operations category. The Oncology Institute, Inc. faces a si...

Oncology Institute's Balancing Act: Navigating Goodwill Impairment Amid Financial Strains

The latest update is out from Oncology Institute, Inc. (TOI). On April 3, 2024, the Company delivered a compelling overview of its financial outcom...

Oncology Institute Unveils Clear Financial Outlook for 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The Oncology Institute (NASDAQ:<a href="https://investorplace.com/stock-quotes/toi-stock-quote/">TOI</a>) just reported results for the first quarter of 2024.<ul><li>The Oncology Institute reported earnings per share of -22 cents. This was below the analyst estimate for EPS of -12 cents.</li><li>The company reported revenue of $94.67 million.</li><li>This was 0.52% worse than the analyst estimate for revenue of $95.16 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/toi-stock-earnings-the-oncology-institute-for-q1-of-2024/">TOI Stock Earnings: The Oncology Institute Misses EPS, Misses Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

TOI Stock Earnings: The Oncology Institute Misses EPS, Misses Revenue for Q1 2024

The Oncology Institute, Inc. (TOI) Q1 2024 Earnings Call Transcript

The Oncology Institute, Inc. (TOI) Q2 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The Oncology Institute (NASDAQ:<a href="https://investorplace.com/stock-quotes/toi-stock-quote/">TOI</a>) just reported results for the second quarter of 2024.<ul><li>The Oncology Institute reported earnings per share of -17 cents. This was below the analyst estimate for EPS of -10 cents.</li><li>The company reported revenue of $98.58 million.</li><li>This was 4.58% worse than the analyst estimate for revenue of $103.31 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/toi-stock-earnings-the-oncology-institute-for-q2-of-2024/">TOI Stock Earnings: The Oncology Institute Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

TOI Stock Earnings: The Oncology Institute Misses EPS, Misses Revenue for Q2 2024

The Oncology Institute GAAP EPS of -$0.17, revenue of $99M misses by $4.31M

The Oncology Institute announces Rob Carter as CFO

Oncology Institute, Inc. ( ($TOI) ) has provided an update. The Oncology Institute, Inc. announced a leadership change as Mihir Shah steps down as ...

Oncology Institute Announces CFO Transition and Strategic Growth Plan

The Oncology Institute (TOI) has joined Lantern's leading specialty care platform. Now, Lantern members will have access to cancer care at any of T...

Comments

Oncology Institute

空売り

Oncology Institute (NASDAQ:TOI) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル